Revenue (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table represents our revenues disaggregated by geography (in thousands):

	For the three months ended March 31,
Geography	2021		2020
Europe, the Middle East and Africa	$	34,800	$	37,928
Other Foreign	55,895		60,521
Total Foreign	90,695		98,449
United States	227,351		230,158
Total Revenues	$	318,046	$	328,607

    The following table represents our revenues disaggregated by product (in thousands):

	For the three months ended March 31,
Product line	2021		2020
Infusion Consumables	$	126,370	$	123,507
Infusion Systems	84,334		88,380
IV Solutions	94,176		104,291
Critical Care	13,166		12,429
Total Revenues	$	318,046	$	328,607

Contract with Customer, Asset and Liability [Table Text Block]

The following table presents our changes in the contract balances for the three months ended March 31, 2021 and 2020 (in thousands):

	Contract Liabilities
Beginning balance, January 1, 2021	$	(6,430)
Equipment revenue recognized	461
Equipment revenue deferred due to implementation	(2,921)
Software revenue recognized	1,796
Software revenue deferred due to implementation	(1,794)
Ending balance, March 31, 2021	$	(8,888)
Beginning balance, January 1, 2020	$	(4,855)
Equipment revenue recognized	1,802
Equipment revenue deferred due to implementation	(3,990)
Software revenue recognized	1,235
Software revenue deferred due to implementation	(2,664)
Ending balance, March 31, 2020	$	(8,472)